Humanigen, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of cell and gene therapies for the treatment of cancers through novel human granulocyte-macrophage colony-stimulating factor neutralization and gene-knockout platforms. The company was founded by Jeng-Horng Her & Robert F. Balint on March 15, 2000 and is headquartered in Burlingame, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2
Frequently Asked Questions
What is Market Cap of Humanigen Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Humanigen Inc market cap is N/A.
What is the 52-week high for Humanigen Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Humanigen Inc 52 week high is N/A as of September 08, 2025.
What is the 52-week low for Humanigen Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Humanigen Inc 52 week low is N/A as of September 08, 2025.
What is Humanigen Inc stock price today?
Humanigen Inc stock price today is $0.50.
What was Humanigen Inc stock price yesterday?
Humanigen Inc stock price yesterday was $0.70.
What is the PE ratio of Humanigen Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Humanigen Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Humanigen Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Humanigen Inc P/B ratio is None.
What is Humanigen Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Humanigen Inc's EBITDA is -17.00.
What is the 50-day moving average of Humanigen Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Humanigen Inc 50-day moving average is N/A.